| Year | Industry | Regulation | Customer category | Project summary |
|---|---|---|---|---|
| 2026 | Pharmaceutical | cGMP | API manufacturer | Supporting the FDA inspection of API manufacturing facility |
| 2026 | Pharmaceutical | cGMP | Medicine manufacturer | GAP analys of investigational drug manufacturing facility (cGMP) |
| 2026 | Pharmaceutical | cGMP | Medicine manufacturer | GAP analys of pharmacutical manufacturing facility (cGMP) |
| 2026 | Pharmaceutical | cGMP | Medicine manufacturer | GAP analys of pharmacutical manufacturing facility (cGMP) |
| 2026 | Pharmaceutical | CSV | API manufacturer | CSV Consulting |
| 2026 | Pharmaceutical | CSV | Medicine manufacturer | ERES/CSV Training |
| 2026 | Pharmaceutical | GMP | API manufacturer | Consultation on Analytical Method Validation for Developmental Products |
| 2026 | Pharmaceutical | GMP | API manufacturer | GMP Consulting |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Basic Design Review for New Plant Construction |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | GMP Improvement Consulting |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | QP Mock Inspection of Formulation Plants |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Review of DQ Plans/Reports for New Plant Construction |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Review of IQ/OQ Plans/Reports for New Plant Construction |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Support for CCS Requirements |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Support for Improving CSV Procedures |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Support for Improving Validation Procedures |
| 2026 | Pharmaceutical | GMP | Medicine manufacturer | Support for VMP Preparation for New Plant Construction |
| 2026 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for Validation Strategy Development Regarding Production Line Changes |
| 2026 | Pharmaceutical | GMP | Regenerative medicine manufacturer | Consultation on Environmental Microorganisms for Aseptic Facilities Review Regarding the Act Against |
| 2026 | Pharmaceutical | GMP | Regenerative medicine manufacturer | Consultation on Key Audit Points for Selecting Contract Manufacturers (Aseptic) |
| 2026 | Pharmaceutical | GMP | Regenerative medicine manufacturer | Evaluation of the Adequacy of Manufacturing Records |
| 2026 | Pharmaceutical | GMP | Regenerative medicine manufacturer | Review of the Verification Plan |
| 2026 | Pharmaceutical | GQP | Pharmaceutical MAH | GQP Training for Regenerative Medicine Products |
| 2026 | Pharmaceutical | Others | Cosmetic MAH | Consultation on Ensuring Safety of Stem Cell Raw Materials |
| 2026 | Pharmaceutical | Others | Medicine manufacturer | Support for Prefilled Syringe Formulation Development |
| 2026 | Pharmaceutical | PMD Act | API manufacturer | API Development Consulting |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Drafting of CTD (M1) Documentation |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Quality Check of CTD (M2, M3) |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for CTD M2 preparation |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for CTD M3 preparation |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for examining anticipated queries and response policies regarding Applications for Marketing Approval |
| 2026 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for responding to query items regarding Applications for Marketing Approval |
| 2026 | Pharmaceutical | PMD Act | Trading company | Pharmaceutical Regulatory Affairs Training for Trading Companies |
| 2026 | Cosmetic | cGMP | Cosmetic manufacturer | GAP analys of pharmacutical manufacturing facility (cGMP) |
| 2026 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Consulting on EFfCI |
| 2026 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP analysis of cosmetic ingredients factory(EFfCI) |
| 2026 | Cosmetic | Others | Cosmetic MAH | Review Regarding the Act against Unjustifiable Premiums and Misleading Representations |
| 2026 | Cosmetic | PMD Act | Cosmetic MAH | Review of Cosmetic Ingredient Labels |
| 2026 | Cosmetic | PMD Act | Quasi-drug MAH | Responding to Inquiries Regarding Quasi-Drug Applications |
| 2026 | Others | CSV | System company | CSV Consulting |
| 2026 | Others | GMP | System company | Training for Annual Reviews |
| 2025 | Pharmaceutical | cGMP | API manufacturer | FDA Mock inspection (cGMP) |
| 2025 | Pharmaceutical | cGMP | Medicine manufacturer | Consultation for establishment of cGMP systems |
| 2025 | Pharmaceutical | cGMP | Medicine manufacturer | Training for FDA Inspections |
| 2025 | Pharmaceutical | cGMP | Pharmaceutical MAH | On-site Facility Investigation for Factory Renovation |
| 2025 | Pharmaceutical | cGMP | Pharmaceutical MAH | Support for improving issues found for FDA inspections |
| 2025 | Pharmaceutical | cGMP | Pharmaceutical MAH | Support for improving issues found for FDA inspections |
| 2025 | Pharmaceutical | cGMP | Pharmaceutical MAH | Training on basic cGMP |
| 2025 | Pharmaceutical | GCP | Pharmaceutical MAH | Consultation for GCP procedure document development |
| 2025 | Pharmaceutical | GCP | Pharmaceutical MAH | Provision of GCP procedure document templates |
| 2025 | Pharmaceutical | GCTP | Medicine manufacturer | GCTP Procedure Development Support |
| 2025 | Pharmaceutical | GMP | API manufacturer | Consultation on manufacturing control and quality control |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Basic Design Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Consultation for PV |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Consultation on Cleanliness of API manufacturing facilities |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Consultation on Safety Management of QC Facilities |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Consulting on Purified Water and HVAC Management in China |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Detailed Design Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | GAP analys of pharmacutical manufacturing facility (GMP) |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | GAP analysis of GMP procedures |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | GMP annual training (3 times in total) |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | IQ/OQ Plan Creation Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | IQ/OQ Report Creation Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | IQ/OQ Work Proxy Services for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | PMDA mock inspection of manufacturing facilities in India |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Training on Test Skipping |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | URS Creation Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | Validation Report Creation Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Medicine manufacturer | VMP Creation Support for New Plant Construction |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP Analysis for Obtaining Pharmaceutical Manufacturing Approval |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP audit training (tablets) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | On-site Facility Investigation for Factory Renovation |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | On-site Facility Investigation for Factory Renovation |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for overseas API manufacturer (GMP) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for overseas manufacturer (GMP) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Pharmaceutical | GMP | Regenerative medicine manufacturer | Support for process verification of investigational products |
| 2025 | Pharmaceutical | GMP | Trading company | Audit interpretation support for manufacturing facilities in India |
| 2025 | Pharmaceutical | GMP | Trading company | GMP audit training for trading company sales staff |
| 2025 | Pharmaceutical | GMP | Trading company | Support for proxy audit of API manufacturing sites in China (GMP) |
| 2025 | Pharmaceutical | GMP | Trading company | Support for proxy audit of API manufacturing sites in China (GMP) |
| 2025 | Pharmaceutical | GMP | Trading company | Support for proxy audit of API manufacturing sites in China (GMP) |
| 2025 | Pharmaceutical | GQP | Pharmaceutical MAH | Support for License Renewal of MAH |
| 2025 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Proxy audit of manufacturing facilities in China (investigational drugs GMP) |
| 2025 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Support for Establishing GMP Organization for Investigational Medicinal Products |
| 2025 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Support for Establishment of Investigational Medicinal Product GMP Procedures |
| 2025 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Support for Establishment of Investigational Medicinal Product GMP Procedures |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Management of manufacturing (packaging and labeling) of investigational new drugs |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Manufacturing (packaging and labeling) management |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Quality evaluation of imported investigational drug lots |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Revision of product standards for investigational drugs |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for establishment of GMP documentation system for investigational drugs |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for establishment of GMP system for investigational drugs |
| 2025 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for feasibility study on GMP operation for investigational drugs |
| 2025 | Pharmaceutical | Investigational Drug GMP | Regenerative medicine manufacturer | Quality system revision support |
| 2025 | Pharmaceutical | Others | Medicine manufacturer | Consultation regarding drug containers |
| 2025 | Pharmaceutical | Others | Pharmaceutical MAH | Import-related services for investigational drugs |
| 2025 | Pharmaceutical | Others | Pharmaceutical MAH | Proxy audit of manufacturing plant for investigational product |
| 2025 | Pharmaceutical | PIC/S GMP | Medicine manufacturer | Consultation for QP Inspection Preparation |
| 2025 | Pharmaceutical | PIC/S GMP | Medicine manufacturer | Training for QP Inspection |
| 2025 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2025 | Pharmaceutical | PMD Act | Medicine manufacturer | CMC consulting for pharmaceutical development |
| 2025 | Pharmaceutical | PMD Act | Medicine manufacturer | Consulting on Pharmaceuticals |
| 2025 | Pharmaceutical | PMD Act | Medicine manufacturer | Support for creating MF |
| 2025 | Pharmaceutical | PMD Act | Pharmaceutical MAH | IMPD review for drug submission |
| 2025 | Pharmaceutical | PMD Act | Pharmaceutical MAH | IMPD translation |
| 2025 | Pharmaceutical | PMD Act | Trading company | Consulting on APIs |
| 2025 | Regenerative medicine | PIC/S GMP | Regenerative medicine manufacturer | Regulatory Seminar on Pharmaceuticals and Regenerative Medicine Products in Australia |
| 2025 | Medical device | GMP | Medical device MAH | Consulting on medical devices |
| 2025 | Medical device | QMS | Medical device MAH | Proxy audit support for medical device manufacture (QMS) |
| 2025 | Medical device | QMS | Medical device MAH | Proxy audit support for medical device manufacture (QMS) |
| 2025 | Medical device | QMS | Medical device MAH | Proxy audit support for medical device manufacture (QMS) |
| 2025 | Medical device | QMS | Medical device manufacturer | GAP Analysis of medical device manufacturer (ISO13485) |
| 2025 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training for API manufacturer |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | cGMP training |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for analytical method validation |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for cGMP documentation system |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for cGMP organization establishment |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for cleaning validation |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for improvement of GAP analysis findings |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for PQ, PV |
| 2025 | Cosmetic | cGMP | Cosmetic MAH | Support for qualification of facilities and equipment |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Audit of packaging, labeling, and storage contractor (Cosmetic GMP) |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Proxy audit of cosmetics storage warehouse (GMP) |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Explanation of ISO 22716 SOP Templates |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | ISO 22716 GAP analysis |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | ISO 22716 Training |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Mock inspections for ISO22716 certification |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Providing ISO 22716 SOP Templates |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Support for Creating ISO 22716 SOPs |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Support for Observation of ISO 22716 Certification Audits |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Support for Quality System improvements to ISO22716 certification |
| 2025 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | Support for Structural and Facility improvements to ISO22716 certification |
| 2025 | Cosmetic | CSV | Cosmetic MAH | Support for CSV of computerized systems |
| 2025 | Cosmetic | PMD Act | Cosmetic MAH | Preliminary investigation for quasi-drug applications |
| 2025 | Cosmetic | PMD Act | Quasi-drug MAH | Support for preparing documents related to QD registration applications |
| 2025 | Construction | CSV | Construction company | CSV training |
| 2025 | Construction | GMP | Construction company | Support for creating e-learning GMP educational materials for facility managers |
| 2025 | Equipment | CSV | Equipment sales company | Support for Development of Incubation Equipment |
| 2025 | Equipment | GMP | Equipment sales company | GMP/Validation Training for Equipment Manufacturers |
| 2025 | Equipment | GMP | Equipment sales company | Training on the Cartagena Act for setting up laboratories |
| 2025 | Equipment | GMP | Medical device manufacturer | Training for Part 11 |
| 2025 | Others | CSV | System company | CSV Compliance Support for Cell Culture Quality Evaluation Systems |
| 2025 | Others | CSV | System company | Support for cell culture quality evaluation systems |
| 2025 | Others | GCP | Medicine manufacturer | Proxy audits of pharmaceutical development facility (GCP) |
| 2025 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2025 | Others | GMP | System company | GMP training for system suppliers |
| 2025 | Others | GMP | Temporary staffing agency | Validation Training |
| 2025 | Others | GQP | Domestic foundation | Seminar on quality control of pharmaceuticals, cosmetics, etc. |
| 2025 | Others | GQP | Pharmaceutical MAH | Proxy audits of pharmaceutical MAH (GQP) |
| 2025 | Others | GQP | Pharmaceutical MAH | Proxy audits of pharmaceutical MAH (GQP) |
| 2025 | Others | Investigational Drug GMP | Educational corporation | Support for creating clinical trial manufacturing reports |
| 2024 | Pharmaceutical | cGMP | API manufacturer | GAP analys of pharmacutical manufacturing facility (cGMP) |
| 2024 | Pharmaceutical | cGMP | Pharmaceutical MAH | Evaluation of Job Description and Education System |
| 2024 | Pharmaceutical | cGMP | Pharmaceutical MAH | GAP Analysis of API Manufacturer (cGMP) |
| 2024 | Pharmaceutical | CSV | System company | Scope study on the implementation of a production management system |
| 2024 | Pharmaceutical | GMP | API manufacturer | Consultation on Cleaning Validation |
| 2024 | Pharmaceutical | GMP | API manufacturer | Consultation on manufacturing control and quality control |
| 2024 | Pharmaceutical | GMP | API manufacturer | Consultation on sampling methods |
| 2024 | Pharmaceutical | GMP | API manufacturer | GAP analys of pharmacutical manufacturing facility (GMP) |
| 2024 | Pharmaceutical | GMP | API manufacturer | GMP Consulting |
| 2024 | Pharmaceutical | GMP | API manufacturer | GMP Consulting (April-August 2024) |
| 2024 | Pharmaceutical | GMP | API manufacturer | GMP Consulting (Sep 2024-Mar 2025) |
| 2024 | Pharmaceutical | GMP | API manufacturer | Support for developing a roadmap for acquiring a pharmaceutical (API) manufacturing business |
| 2024 | Pharmaceutical | GMP | Architectural Design Company | Support for laboratory facility evaluations |
| 2024 | Pharmaceutical | GMP | Architectural Design Company | Training for GMP |
| 2024 | Pharmaceutical | GMP | Drug discovery company | Initial survey of manufacturing facility (Laboratory) |
| 2024 | Pharmaceutical | GMP | Drug discovery company | Support for analyzing the current situation and drafting a Roadmap for development |
| 2024 | Pharmaceutical | GMP | Material manufacturer | Conceptual design support for facility improvement |
| 2024 | Pharmaceutical | GMP | Material manufacturer | Design management improvement support |
| 2024 | Pharmaceutical | GMP | Material manufacturer | GMP organization and document system establishment |
| 2024 | Pharmaceutical | GMP | Material manufacturer | GMP training |
| 2024 | Pharmaceutical | GMP | Material manufacturer | Support for coordination with customers on quality |
| 2024 | Pharmaceutical | GMP | Material manufacturer | Support for development of GMP procedures |
| 2024 | Pharmaceutical | GMP | Material manufacturer | Support for validation of facilities |
| 2024 | Pharmaceutical | GMP | Medical device MAH | Support for GMP GAP analysis of QMS system |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | GAP analys of pharmacutical manufacturing facility |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | General training on GMP |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | General training on GMP |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | GMP annual training (5 times in total) |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | GMP Compliance Investigation of Pharmaceutical Manufacturing Facilities |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | GMP training support for education and training personnel |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | Group work for GMP knowledge improvement |
| 2024 | Pharmaceutical | GMP | Medicine manufacturer | Support for proxy audit representation of API manufacturing facilities in India |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Assist in reviewing drawings for pharmaceutical plant renovations |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Audit interpretation support for pharmaceutical wholesaler warehouses |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Consultation on Analytical Method Validation |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Consultation on formulation application |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Consulting for GMP, QMS, pharmaceutical regulations, etc. |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP Analysis of formulation plants (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP Analysis of Injectable Drug Plants (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP audit training (API) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Improvement plans and responses to reports on issues raised following GMP compliance inspections |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Interpretation support for audits to select contractors |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Interpretation support for overseas manufacturing facility audits (English/Japanese) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Mock inspection (remote) of formulation plants |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Mock inspections of domestic packaging and testing contractors |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Mock inspections of domestic packaging contractors |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Mock inspections of domestic testing contractors |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | On-site consulting for QC operations |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Pre-audit for API manufacturer in USA (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Pre-audit for domestic packaging contractors (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Pre-audit for domestic testing contractors (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Pre-audit for formulation manufacturer in USA (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Preparation for GMP compliance inspection |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of starting material manufacturing facilities |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of starting material manufacturing facilities |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Quality evaluation by inspection of tablets |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Research for manufacturing transfer |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of audit results improvement plans and reports |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of product specifications |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for advance preparation of inquiries for drug manufacturing and marketing approval |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for drafting instruction |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for mock inspections of overseas API manufacturers |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for mock inspections of overseas API manufacturers |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for mock inspections of overseas formulation manufacturers |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for mock inspections of overseas formulation manufacturers |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for proxy audits of manufacturing facilities |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Training for GMP compliance inspection |
| 2024 | Pharmaceutical | GMP | Pharmaceutical MAH | Training of training personnel for GMP education |
| 2024 | Pharmaceutical | GMP | Regenerative medicine MAH | GMP audit of overseas manufacturing sites (Desktop) |
| 2024 | Pharmaceutical | GMP | Trading company | Interpretation for audits of overseas API manufacturing facilities |
| 2024 | Pharmaceutical | GMP | Trading company | Support for creation of OOS procedures |
| 2024 | Pharmaceutical | GMP | Trading company | Support for proxy audit of API manufacturing sites in China (GMP) |
| 2024 | Pharmaceutical | GQP | Pharmaceutical MAH | Support for creating procedures for MAH certification |
| 2024 | Pharmaceutical | GQP | Pharmaceutical MAH | Support for review and finalization of quality contracts |
| 2024 | Pharmaceutical | GQP | Pharmaceutical MAH | Support for review of procedures related to the manufacture and marketing authorsation of pharmaceutical products |
| 2024 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Support for proxy audit of API manufacturing sites in China (Investigational new drug GMP) |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Packaging company's production of investigational drugs is evaluated. |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Proxy audits for Investigational New Drug manufacturer(Investigational New Drug GMP) |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for creating investigational product master formula |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for evaluation of suppliers regarding the introduction of investigational new drugs |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for PTP packaging of pharmaceutical products |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for quality assessment of investigational new drugs |
| 2024 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for release decision from overseas manufacturing facilities |
| 2024 | Pharmaceutical | Others | API manufacturer | Consultation on containment of genotoxic agents |
| 2024 | Pharmaceutical | Others | Medicine manufacturer | Proxy audits of API Manufacturer (GMP) |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | CMC consultation for development candidates |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Confirmation of preliminary stability testing results |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Consultation on policy for MAH certification |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Quality contract review of overseas manufacturing facilities (APIs and drug product) |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Quality control of investigational new drugs (up to in-licensing of investigational new drugs) |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Recruiting Support |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Regulatory Studies in Asia |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Research and training seminars on Chinese laws and regulations |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Support for coordination with packaging/testing contractors |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Support for development of a proposal for the establishment of a new department |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Support for review of quality contracts for domestic manufacturing facilities |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Support for Stability Testing |
| 2024 | Pharmaceutical | Others | Pharmaceutical MAH | Support for the preparation of preliminary stability testing protocols |
| 2024 | Pharmaceutical | Others | Regenerative medicine MAH | Review of quality contracts |
| 2024 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2024 | Pharmaceutical | PMD Act | Foundation | Support for application for approval of the manufacture of specific cellular processed products |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Confirmation and evaluation of stability testing results for PTP packaging and assistance with preliminary stability testing |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for changes in laboratory test methods |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for Manufacturing Businesses for Medical Devices |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for packaging and labeling |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation on OEL and PDE |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation support for CTD preparation (including reporting) |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | CTD M1 document draft review support |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Pharmaceutical consultation regarding relocation of contractors |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Revew for CTD(M2.3) |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Review of accelerated test results report |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Review of CTD M2.3 and M3 |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Review of Drug Approval Applications |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Review of Long-term shelf-life testing result reports |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Suport for translation of CTD |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for CTD M2.3 preparation |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for CTD M3 preparation |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for development of CTD M2.3 and M3 preparation policy |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for obtaining stability test specimens and standards |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for preparation of documentary research materials |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for preparation of stability test protocols |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for proxy audit of testing contractors [Reliability standards]. |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for responding to PMDA inquiries (M2.3,M3) |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for scheduling stability tests |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for validation of microbiological tests |
| 2024 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Training on pharmaceutical affairs |
| 2024 | Pharmaceutical | PMD Act | Trading company | Consultation for Master File Creation |
| 2024 | Pharmaceutical | PMD Act | Trading company | Consultation support regarding related substances |
| 2024 | Pharmaceutical | PMD Act | Trading company | Review of Master File |
| 2024 | Regenerative medicine | GCTP | Educational corporation | Proxy audits of CPC facilities (GCTP) |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Construction support of regenerative medical product systems |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Creation of trilateral guideline list |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Formulation of development policy for regenerative medical products |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Prepare and provide GCTP procedures |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Prepare and provide GCTP procedures |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Support for the development of a strategic plan for the management of regenerative medicine products |
| 2024 | Regenerative medicine | GCTP | Regenerative medicine MAH | Support for the development of regenerative medicine product management strategies |
| 2024 | Regenerative medicine | Investigational Drug GMP | Medicine manufacturer | Proxy audits of domestic CPC facilities |
| 2024 | Regenerative medicine | Investigational Drug GMP | Regenerative medicine MAH | Proxy audit of manufacturing plant for investigational product |
| 2024 | Regenerative medicine | Others | Regenerative medicine MAH | Support for establishment of an organization related to the structure of the clinical trial |
| 2024 | Regenerative medicine | Others | Regenerative medicine MAH | Support for preparation of procedures related to the clinical trial system |
| 2024 | Regenerative medicine | Others | Regenerative medicine MAH | Training on clinical trial structure |
| 2024 | Regenerative medicine | Others | Regenerative medicine manufacturer | Investigation of legal requirements for conducting clinical trials in Australia |
| 2024 | Regenerative medicine | PIC/S GMP | Regenerative medicine manufacturer | GAP analysis of investigational new drug manufacturing facilities(PIC/S GMP Annex2a) |
| 2024 | Medical device | GMP | Pharmaceutical MAH | Proxy audit of pharmaceutical manufacturer (GMP) |
| 2024 | Medical device | QMS | Medical device MAH | Proxy audit support for medical device warehouses |
| 2024 | Medical device | QMS | Medical device MAH | Revision of risk management SOP's |
| 2024 | Medical device | QMS | Medical device MAH | Support for creating Usability Engineering Procedures |
| 2024 | Medical device | QMS | Medical device MAH | Training for risk management |
| 2024 | Medical device | QMS | Medical device MAH | Training support for SOPs related to QMS |
| 2024 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | GMP Elementary Training Support |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | GAP analysis of a cosmetics factory warehouse(cGMP) |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | GAP analysis of a cosmetics factory(cGMP) |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | GAP analysis of domestic cosmetics manufacturing facilities(cGMP) |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | Making SOP temprate (cGMP) |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | Support for Establishment of GMP Documentation System |
| 2024 | Cosmetic | cGMP | Cosmetic MAH | Support for Establishment of GMP Organization System |
| 2024 | Cosmetic | Cosmetic GMP | Cosmetic MAH | GAP analysis of a cosmetics factory(ISO22716) |
| 2024 | Cosmetic | Cosmetic GMP | Cosmetic MAH | GAP analysis of a cosmetics factory(ISO22716) |
| 2024 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP Analysis of Cosmetic Ingredient Manufacturing Facility |
| 2024 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP analysis of cosmetic ingredients factory (ISO9001・EFfCI) |
| 2024 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Support for developing a CSV implementation plan for a cosmetics raw materials factory |
| 2024 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Support for the development of a structural facility improvement plan for a cosmetics raw materials factory |
| 2024 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Support for the development of a structural facility improvement plan for a cosmetics raw materials factory |
| 2024 | Material | CSV | Material manufacturer | Confirmation of current system specifications |
| 2024 | Material | CSV | Material manufacturer | Study of systems for additional lines |
| 2024 | Material | CSV | Material manufacturer | Support for business-related IT system studies |
| 2024 | Material | CSV | Material manufacturer | Support for CSV (PQ) of existing IT systems |
| 2024 | Material | CSV | Material manufacturer | Vendor selection support for IT system implementation |
| 2024 | Material | GMP | Equipment sales company | Training support for regulations related to pharmaceutical manufacturing equipment |
| 2024 | Material | GMP | Material manufacturer | Basic plan and basic design development for additional lines |
| 2024 | Material | GMP | Material manufacturer | Design support for buildings and building equipment for factory construction |
| 2024 | Material | GMP | Material manufacturer | PQ support for existing production facilities |
| 2024 | Material | GMP | Material manufacturer | Review of specifications for water facilities |
| 2024 | Material | GMP | Material manufacturer | Support for basic planning of buildings and building facilities |
| 2024 | Material | GMP | Material manufacturer | Support for installation of water facilities |
| 2024 | Material | GMP | Material manufacturer | Support for validation of production facilities (equipment listing and VMP Creation) |
| 2024 | Material | GMP | Material manufacturer | URS and DQ support for introduction of water facilities for production |
| 2024 | Material | GMP | Material manufacturer | URS and PQ support for production facilities in factory construction |
| 2024 | Material | GMP | Material manufacturer | VMP and URS creation support for building facilities in factory construction |
| 2024 | Material | Others | Material manufacturer | Construction of ISO 15378 related documents |
| 2024 | Material | Others | Material manufacturer | Documentation support for ISO15378 |
| 2024 | Material | Others | Material manufacturer | GAP analysis of documents for ISO 15378 certification |
| 2024 | Construction | GMP | Architectural Design Company | GMP training for pharmaceutical manufacturing plant construction |
| 2024 | Construction | GMP | Construction company | Training about URS |
| 2024 | Construction | GMP | Construction company | Training for CSV |
| 2024 | Construction | GMP | Construction company | Training on Impact Assessment |
| 2024 | Construction | GMP | Construction company | Validation Document Review |
| 2024 | Equipment | CSV | Equipment sales company | Consultation for CSV |
| 2024 | Equipment | CSV | Equipment sales company | Training for CSV |
| 2024 | Equipment | CSV | Trading company | DI support for development systems |
| 2024 | Equipment | Others | Equipment sales company | Support for test method development |
| 2024 | Others | CSV | System company | CSV support for systems |
| 2024 | Others | GMP | Pharmaceutical manufacturing component manufacturer | GAP analysis of manufacturing facilities for Biopharmaceutical Manufacturing Components (GMP) |
| 2024 | Others | GMP | Pharmaceutical manufacturing component manufacturer | Support for improvement plans for findings from audits |
| 2024 | Others | GMP | Public-service corporation | Seminar on Pharmaceutical Quality System |
| 2024 | Others | GMP | System company | Training for CSV |
| 2024 | Others | Others | System company | Support for accompanying the client to check the current status for system proposal |
| 2024 | Others | QMS | Logistics company | Web consultation on obtaining a medical device manufacturing license, etc. |
| 2023 | Pharmaceutical | cGMP | API manufacturer | Check deviation/change control, OOS/OOT, and validation records |
| 2023 | Pharmaceutical | cGMP | API manufacturer | FDA Inspection Training |
| 2023 | Pharmaceutical | cGMP | API manufacturer | FDA Mock Inspections for API Plant |
| 2023 | Pharmaceutical | cGMP | API manufacturer | Support for handling findings during FDA mock inspections |
| 2023 | Pharmaceutical | cGMP | API manufacturer | Training for cGMP |
| 2023 | Pharmaceutical | cGMP | API manufacturer | Training for cGMP |
| 2023 | Pharmaceutical | cGMP | Medicine manufacturer | Deployment/confirmation of job description |
| 2023 | Pharmaceutical | cGMP | Medicine manufacturer | Mock audit of investigational drug manufacturing plant (injectable drug) |
| 2023 | Pharmaceutical | cGMP | Medicine manufacturer | Prepare/provide training materials for responsible personnel |
| 2023 | Pharmaceutical | cGMP | Medicine manufacturer | Support for consideration of education and training management methods |
| 2023 | Pharmaceutical | cGMP | Medicine manufacturer | Transition to a document management system for training records etc |
| 2023 | Pharmaceutical | cGMP | Pharmaceutical MAH | Organization/Design of Job Descriptions |
| 2023 | Pharmaceutical | cGMP | Pharmaceutical MAH | Organization/design of training programs |
| 2023 | Pharmaceutical | cGMP | Pharmaceutical MAH | Organization/design of training records |
| 2023 | Pharmaceutical | CSV | Medicine manufacturer | CSV Training |
| 2023 | Pharmaceutical | CSV | Medicine manufacturer | Training for CSV guidelines |
| 2023 | Pharmaceutical | GMP | API manufacturer | Audit for Quality Management System for API manufacturer |
| 2023 | Pharmaceutical | GMP | API manufacturer | FDA Mock inspection of API Manufacturer (cGMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | GMP consulting for API manufacturer |
| 2023 | Pharmaceutical | GMP | API manufacturer | On-the-job training for self-inspection |
| 2023 | Pharmaceutical | GMP | API manufacturer | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | API manufacturer | Support for LIMS implementation |
| 2023 | Pharmaceutical | GMP | API manufacturer | Training for self-inspection |
| 2023 | Pharmaceutical | GMP | Foundation | PMDA Mock Inspection of Overseas pharmaceutical Manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Consultation for manufacturing API |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | FAT surpport for preparation of pharmaceutical manufacturing plant |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | GAP analysis for pharmaceutical manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits for overseas manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits for Pharmaceutical manufacturer (Investigational Drug GMP) |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Research support for Reconstruction of pharmaceutical production area |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Review of basic and detailed design documents for the construction of pharmaceutical manufacturing plant |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for aseptic manufacturing area reconstruction layout study |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for DQ plan preparation of pharmaceutical manufacturing plant |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for investigation of estimated cost for reconstruction of the sterile drug product manufacturing area |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for IOQ plan review of pharmaceutical manufacturing plant |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for preparation of architectural URS and VMP for pharmaceutical manufacturing plant |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for preparation of conceptual design for reconstruction of the sterile drug product manufacturing area |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for review of procedures related to DI |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for review of procedures related to education and training |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Support for survey of current conditions for vector production |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Training for aseptic formulation(PIC/S ANEEX1) |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Training for compliance in pharmaceutical manufacturing |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Training for DI |
| 2023 | Pharmaceutical | GMP | Medicine manufacturer | Training for technology transfer |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Comprehensive consulting for pharmaceuticals |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Consultation on contract manufacturing management |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Evaluation of manufacturing line drawings for high pharmacological formulation |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP Analysis of Pharmaceutical Manufacturer |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP document inspection |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP document Revision |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Pharmaceutical Affairs consultation on packaging |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for overseas API manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for overseas manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for overseas manufacturer (GMP) |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of CTD |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of validation documents |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for creating procedures related to manufacturing equipment |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for research on development data |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for revision of master batch records |
| 2023 | Pharmaceutical | GMP | Pharmaceutical MAH | Virtual GMP audit training (Sterile Medical Products) |
| 2023 | Pharmaceutical | GMP | Quasi-drug MAH | Conslutation on quasi-drug |
| 2023 | Pharmaceutical | GMP | System company | GMP Seminar |
| 2023 | Pharmaceutical | GMP | Trading company | Consulting on API quantification methods |
| 2023 | Pharmaceutical | GMP | Trading company | First GMP proxy audit on behalf of API plants in China |
| 2023 | Pharmaceutical | GMP | Trading company | Periodic GMP proxy audit on behalf of API plants in China |
| 2023 | Pharmaceutical | GMP | Trading company | Proxy audit of API Manufacturing Facility in India (GMP) |
| 2023 | Pharmaceutical | GMP | Trading company | Self-inspection at warehouse facilities(Packaging, labeling, storage) |
| 2023 | Pharmaceutical | GQP | Pharmaceutical MAH | Referral assistance for General Marketing compliance Officer |
| 2023 | Pharmaceutical | GVP | Pharmaceutical MAH | Sales of GVP procedures |
| 2023 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Consultation on investigational drug stability testing |
| 2023 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Consultation on manufacturing of APIs for clinical trials |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Audit of packaging contractors for investigational new drugs |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Evaluation of Investigational New Drug Supplier |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Examination of domestic packaging and labeling specifications for investigational new drug |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Investigational new drug transport mode study |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Management of importation and storage of pharmaceutical products on behalf of the company |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Management of packaging, storage, and delivery of investigational drugs on behalf of the company |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Preparation of documents related to the investigational new drug |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Preparation of Quality Arrangements |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Quality Assessment of Investigational New drug |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Quality control operations on behalf of the company |
| 2023 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Support for establishment of procedures for investigational new drugs GMP |
| 2023 | Pharmaceutical | Others | Pharmaceutical MAH | Consultation for pharmaceutical business |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation and evaluation of PTP sheets |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for contract laboratory |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation on product labels for pharmaceutical Drug Product |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Pharmaceutical Affairs Consultation for Excipients |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Pharmaceutical consultation for drug additives |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Pharmaceutical consultation for reference material |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for FD application data review |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for pharmaceutical consultation regarding M1.2 |
| 2023 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Support for responding to PMDA inquiries |
| 2023 | Medical device | CSV | Medical device manufacturer | Support for creation of CSV-related business standards |
| 2023 | Medical device | Others | Medical device MAH | Consultation for GLP |
| 2023 | Medical device | PMD Act | Medical device MAH | Support for preparation of application for patical changes documents |
| 2023 | Medical device | QMS | Medical device MAH | Consultation for Revised QMS Regulations |
| 2023 | Medical device | QMS | Medical device MAH | Consultation for vaccine filling facilities |
| 2023 | Medical device | QMS | Medical device MAH | On-site consulting for QA operations |
| 2023 | Medical device | QMS | Medical device MAH | On-site consulting for QA operations |
| 2023 | Medical device | QMS | Medical device MAH | Review of revised procedures regarding QMS |
| 2023 | Medical device | QMS | Medical device MAH | Self-inspection of medical device MAH |
| 2023 | Medical device | QMS | Medical device MAH | Self-inspection of medical device manufacturers (QMS) |
| 2023 | Medical device | QMS | Medical device MAH | Support for QMS document review |
| 2023 | Medical device | QMS | Pharmaceutical MAH | Preparation support for medical device MAH update audits |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | FDA Inspection Interpreter (Japanese/English) |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | GAP analysis for API manufacturer (cGMP) |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | GAP analysis for API manufacturer (cGMP) |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | GMP trainning for API manufacturer |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Support for preparation for FDA inspection |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Support for response to FDA findings (Form 483) |
| 2023 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Supporting the FDA inspection of API manufacturing facility |
| 2023 | Cosmetic | Cosmetic GMP | Quasi-drug MAH | Proxy audit of Cosmetics Manufacturer (Cosmetic GMP) |
| 2023 | Cosmetic | Others | Cosmetic MAH | Consultation on OTC drugs for the U.S. |
| 2023 | Material | GMP | Equipment sales company | Validation consulting for equipment manufacturer |
| 2023 | Material | GMP | Material manufacturer | Concept design and planning support for new facility construction |
| 2023 | Material | Others | Material manufacturer | Review of product specifications |
| 2023 | Equipment | CSV | System company | Training for Validation/CSV implementation |
| 2023 | Equipment | GMP | Equipment sales company | Training for equipment manufacturers about validation |
| 2023 | Equipment | GMP | Equipment sales company | Training for equipment manufacturers about validation |
| 2023 | Equipment | GMP | Equipment sales company | Validation consulting for equipment manufacturer |
| 2023 | Others | CSV | System company | CSV support for production management systems |
| 2023 | Others | GCP | Medicine manufacturer | Proxy audits of pharmaceutical development facility (GCP) |
| 2023 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2023 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2023 | Others | GMP | Medicine manufacturer | Proxy audits of pharmaceutical manufacture (GMP) |
| 2023 | Others | GQP | Medicine manufacturer | Proxy audits of pharmaceutical MAH (GQP) |
| 2023 | Others | GQP | Pharmaceutical MAH | Creation of audit checklist (GMP) |
| 2023 | 当局対応 | GMP | Pharmaceutical MAH | Support for responding to PMDA inquiries |
| 2022 | Pharmaceutical | cGMP | Medicine manufacturer | GAP analysis for laboratories (cGMP) |
| 2022 | Pharmaceutical | cGMP | Medicine manufacturer | Support for evaluation of cGMP compliance for export of investigational API to the U.S. |
| 2022 | Pharmaceutical | CSV | API manufacturer | Advice for warehouse management system installation |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | Creation of URS |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | Creation of Validation Master Plan |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | CSV report preparation |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | DQ surpport |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | FAT surpport |
| 2022 | Pharmaceutical | CSV | Medicine manufacturer | IQ/OQ surpport |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | Review of system specifications for installation of a scratch system |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | Support for DQ review of scratch system implementation |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | Support for IQ review scratch system implementation |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | Support for OQ review scratch system implementation |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | Support for review of validation plan for scratch system implementation |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | URS Review for Scratch System Installation |
| 2022 | Pharmaceutical | CSV | Pharmaceutical MAH | URS review support for scratch system implementation |
| 2022 | Pharmaceutical | CSV | System company | CSV training for system vendors |
| 2022 | Pharmaceutical | GMP | API manufacturer | GAP analysis of API manufacturer (GMP) |
| 2022 | Pharmaceutical | GMP | API manufacturer | GMP Consulting |
| 2022 | Pharmaceutical | GMP | API manufacturer | GMP training |
| 2022 | Pharmaceutical | GMP | API manufacturer | Support for cleaning validation of common equipment |
| 2022 | Pharmaceutical | GMP | API manufacturer | Support for establishment of pharmaceutical quality system |
| 2022 | Pharmaceutical | GMP | APIs intermediates manufacturer | GMP consulting for API intermediate manufacturer |
| 2022 | Pharmaceutical | GMP | Foundation | PMDA Mock Inspection of Overseas Biological Drug Manufacturing Sites |
| 2022 | Pharmaceutical | GMP | Medical device MAH | Organize requirements for setting up a GMP manufacturing facility |
| 2022 | Pharmaceutical | GMP | Medical device MAH | Organizing requirements for pharmaceutical manufacturing applications (GCTP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | CAPA Plan Review of GAP Analysis Findings |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Consultation for Reference Standard |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Creation of Validation Master Plan |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | GAP analysis of GMP procedures |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | GAP analysis of pharmaceutical Manufacturer (EU GMP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | GMP training |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Instruction on equipment calibration and periodic inspections |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Interpretation support for pharmaceutical-related business |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits of API Manufacturer (GMP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Proxy for paper audit (GMP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Proxy for paper audit of overseas API manufacturer (GMP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for environmental validation documentation and execution |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for PQ documentation and execution of equipment and facilities |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for preparation of tertiary documents related for GMP |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for revalidation of relocated equipments |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for SOP restructuring study (GMP) |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for sterilization validation documentation and execution |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support for temperature mapping documentation and execution |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support forGrowth Promotion Test documentation and execution |
| 2022 | Pharmaceutical | GMP | Medicine manufacturer | Support the creation of Transport Verification documentationand execution |
| 2022 | Pharmaceutical | GMP | Pharmaceutical MAH | Interpretation for PMDA remote inspections of overseas API manufacturer |
| 2022 | Pharmaceutical | GMP | Pharmaceutical MAH | Interpretation for PMDA remote inspections of overseas API manufacturing sites |
| 2022 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits of pharmaceutical manufacture (GMP) |
| 2022 | Pharmaceutical | GMP | Pharmaceutical MAH | Support on supplier audits of scratch system implementation |
| 2022 | Pharmaceutical | GMP | Pharmaceutical MAH | Training about MF |
| 2022 | Pharmaceutical | GMP | Trading company | GMP Training for Management |
| 2022 | Pharmaceutical | GMP | Trading company | Proxy audits for overseas API manufacturer (GMP) |
| 2022 | Pharmaceutical | GMP | Trading company | Training of management on pharmaceutical quality systems |
| 2022 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Development support in investigational drug manufacturing |
| 2022 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | GAP Analysis (Investigational Drug GMP) |
| 2022 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audit of investigational drug manufacturer (Investigational Drug GMP) |
| 2022 | Pharmaceutical | Others | API manufacturer | Support for registration with the U.S. DMF |
| 2022 | Pharmaceutical | Others | Medicine manufacturer | Serialization Overview Training |
| 2022 | Pharmaceutical | Others | Pharmaceutical MAH | Consultation for contamination with foreign materials |
| 2022 | Pharmaceutical | PMD Act | Medical device MAH | Evaluation of Elemental Impurities |
| 2022 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for tablet imprinting |
| 2022 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Making MF draft |
| 2022 | Pharmaceutical | PMD Act | Regenerative medicine MAH | Support for evaluation of elemental impurities (ICH Q3D) |
| 2022 | Pharmaceutical | PMD Act | Trading company | Investigation to set specifications |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Investigation of the current status of regenerative medicine product development data |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Support for compilation of development data |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Support for compiling data to determine manufacturing process |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Support for compiling data to determine test criteria and methods |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Support for Risk Assessment |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Technical training on development |
| 2022 | Regenerative medicine | GCP | Regenerative medicine MAH | Training for Drug Product Development |
| 2022 | Regenerative medicine | GCTP | Educational corporation | Documentation Support (GCTP) |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine MAH | Investigation into the current status of quality assurance for shipments of regenerative medicine products |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine MAH | Record review for shipments of regenerative medicine products |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine manufacturer | Basic design support for CPC construction |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine manufacturer | Basic planning support for CPC construction |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine manufacturer | Detailed design support for CPC construction |
| 2022 | Regenerative medicine | GCTP | Regenerative medicine manufacturer | Support in organizing manufacturing and test processes for CPC construction |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Advise of PQ for factory build out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Initial GMP training for manufacturing regenerative medicine products |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Investigation of regenerative medical product manufacturing facilities |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | IQ/OQ documentation for factory build out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Organize requirements and prepare UR for factory build-out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Preparation of DQ for factory build out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Proxy audit of intermediate manufacturing plant for regenerative medicine combination products |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Review of basic design for factory build out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Review of detailed design for factory build out |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Support for determination of quality requirements for manufacturers of intermediates of combination products for regenerative medicine |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Support for GMP document development for manufacturing of regenerative medicine products |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Support for improvement of manufacturing facilities for regenerative medical products |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Technical training on GMP |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | Validation Implementation Status Investigation for Manufacturing and Testing Facilities |
| 2022 | Regenerative medicine | GMP | Regenerative medicine MAH | VMP and URS preparation for factory build out |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Basic traning of Investigational Drug GMP |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Explanation of GMP PQS Procedures of Investigational New Drugs for Physician-Initiated Clinical Trials |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Review of investigational drug manufacturing docymentented manufactuuring orders for investigator-initiated clinical trials |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Support for creating a template for creating procedure manuals (Investigational Drug GMP) |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Support for development of investigational drug GMP documents for investigator-initiated clinical trials |
| 2022 | Regenerative medicine | Investigational Drug GMP | Educational corporation | Support for establishment of investigational drug GMP organization for investigator-initiated clinical trials |
| 2022 | Regenerative medicine | Investigational Drug GMP | Regenerative medicine MAH | Support for determination of in-process testing and quality test criteria |
| 2022 | Regenerative medicine | Investigational Drug GMP | Regenerative medicine MAH | Support for investigational drug manufacturing |
| 2022 | Regenerative medicine | Investigational Drug GMP | Regenerative medicine MAH | Support for preparation of investigational drug product master formula |
| 2022 | Regenerative medicine | Investigational Drug GMP | Regenerative medicine MAH | Support for Test Method Validation |
| 2022 | Regenerative medicine | Others | Drug discovery company | Support for licensing out of pharmaceutical products |
| 2022 | Regenerative medicine | PMD Act | Regenerative medicine MAH | Investigate regenerative medicine combination product development data |
| 2022 | Regenerative medicine | PMD Act | Regenerative medicine MAH | Investigation of the current status of regenerative medicine product development data |
| 2022 | Regenerative medicine | QMS | Regenerative medicine MAH | GAP Analysis (QMS) |
| 2022 | Medical device | CSV | Medical device MAH | Create and review IQ reports for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Create and review OQ plan for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Create and review OQ reports for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Creation of URS for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | Creation of URS for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | DQ/IQ/OQ document review for QMS management system upgrades |
| 2022 | Medical device | CSV | Medical device MAH | DQ/IQ/OQ document review for QMS management system upgrades |
| 2022 | Medical device | CSV | Medical device MAH | Drafting of operational management procedures for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Organize draft operating procedures for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Performing PQ for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | PQ documentation and PQ implementation for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | PQ documentation and PQ implementation for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | PQ plan drafting for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | PQ scenario and script drafting for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Prepared validation report for warehouse management system installation |
| 2022 | Medical device | CSV | Medical device MAH | Validation plan drafting for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | Validation plan drafting for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | Validation report preparation for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device MAH | Validation report preparation for QMS management system upgrade |
| 2022 | Medical device | CSV | Medical device manufacturer | Support for CSV document development |
| 2022 | Medical device | CSV | Medical device manufacturer | Support for policy discussions for CSV document development |
| 2022 | Medical device | CSV | Medical device manufacturer | Support for SOP creation related to CSV |
| 2022 | Medical device | CSV | Medical device manufacturer | Support for the discussion of policies for the development of CSV documentation |
| 2022 | Medical device | Others | Medical device MAH | Support for Stability testing |
| 2022 | Medical device | QMS | Cosmetic MAH | Proxy audit of medical device storage contractor (QMS) |
| 2022 | Medical device | QMS | Medical device MAH | Support for determination of quality requirements for manufacturer of combination products for regenerative medicine etc. |
| 2022 | Medical device | QMS | Medical device MAH | Support for QMS improvement |
| 2022 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP consulting for API manufacturer |
| 2022 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training for API manufacturer |
| 2022 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Proxy audit of cosmetics storage contractor(Cosmetic GMP) |
| 2022 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Proxy audit(Cosmetic GMP) |
| 2022 | Cosmetic | Cosmetic GMP | Material manufacturer | Proxy audit of cosmetics storage contractor(Cosmetic GMP) |
| 2022 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | EFfCI GMP Improvement Consulting for Cosmetics Manufacturer |
| 2022 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP Analysis of Cosmetic Ingredient Manufacturing Plant (EFfCI GMP) |
| 2022 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Support for review of proposed product filling room modifications |
| 2022 | Cosmetic | PMD Act | Medical device MAH | Investigation to apply for permission to use colorants in Japan |
| 2022 | Material | GMP | Material manufacturer | Create and review master batch records |
| 2022 | Material | GMP | Material manufacturer | Creation of roadmap for validation (GMP) |
| 2022 | Material | GMP | Material manufacturer | Creation of Validation Master Plan |
| 2022 | Material | GMP | Material manufacturer | GAP Analysis for Material Manufacturing Plants (GMP) |
| 2022 | Material | GMP | Material manufacturer | Investigation of the current status of validation |
| 2022 | Material | GMP | Material manufacturer | Provide a validation procedure template |
| 2022 | Material | GMP | Material manufacturer | Review of IOQ Plan/Report |
| 2022 | Material | GMP | Material manufacturer | Review of PQ Plan/Report |
| 2022 | Material | GMP | Material manufacturer | Review of PV Plan/Report |
| 2022 | Material | GMP | Material manufacturer | Support for preliminary study of equipment and facilities for new factory |
| 2022 | Material | GMP | Material manufacturer | Support for preliminary study of manufacturing process |
| 2022 | Material | GMP | Material manufacturer | Support for preliminary study of packaging specifications |
| 2022 | Construction | GMP | Construction company | Engineering support for warehouse construction |
| 2022 | Equipment | CSV | Equipment sales company | Consultation on CSV support for image inspection equipment (GMP) |
| 2022 | Equipment | CSV | Equipment sales company | Provide ER/ES and Part 11 checklists |
| 2022 | Equipment | CSV | Equipment sales company | Provide supplier written audit list in CSV for imaging inspection equipment |
| 2022 | Equipment | QMS | Equipment sales company | Support for consultation on validation of imaging inspection equipment |
| 2022 | Equipment | QMS | Equipment sales company | Support for creation of validation documentation for imaging inspection equipment (DQ, IQ, OQ) |
| 2022 | Equipment | QMS | Equipment sales company | Support for Validation Document Review of Imaging and Inspection Equipment (DQ) |
| 2022 | Equipment | QMS | Equipment sales company | Validation training for equipment suppliers |
| 2022 | Others | CSV | Clinical laboratory testing company | CSV document drafting for installation of maintenance management system |
| 2022 | Others | CSV | Clinical laboratory testing company | CSV document review for maintenance management system installation |
| 2022 | Others | GMP | Analysis company | GAP analysis of laboratory (GMP) |
| 2022 | Others | GMP | Event company | DI Seminar |
| 2021 | Pharmaceutical | cGMP | API manufacturer | cGMP consulting |
| 2021 | Pharmaceutical | cGMP | Medicine manufacturer | GAP analysis for pharmaceutical manufacturer (cGMP) |
| 2021 | Pharmaceutical | cGMP | Pharmaceutical MAH | cGMP consulting for API manufacturer |
| 2021 | Pharmaceutical | CSV | Medicine manufacturer | Consulting for system implementation |
| 2021 | Pharmaceutical | CSV | Medicine manufacturer | CSV consulting (GMP) |
| 2021 | Pharmaceutical | GDP | Certification body | Seminar of GDP |
| 2021 | Pharmaceutical | GMP | API manufacturer | Confirmation for CAPA plan (GMP) |
| 2021 | Pharmaceutical | GMP | API manufacturer | GMP consulting for API manufacturer |
| 2021 | Pharmaceutical | GMP | API manufacturer | Proxy audits of starting material manufacturing facilities |
| 2021 | Pharmaceutical | GMP | Foundation | J-GMP Seminar for Overseas Pharmaceutical Manufacturers |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Basic design support for the construction of an injectable drug manufacturing plant |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Conceptual design review for the construction of a pre-filled syringe manufacturing line |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Conceptual design support for construction of an injectable drug manufacturing plant |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Consultation for Validation of Packaging |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Consultation of microbial control (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Detailed design review of pre-filled syringe manufacturing line installation |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Detailed design support for the construction of an injectable drug manufacturing plant |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Evaluation of microbial control (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Feasibility study support for the construction of an injection drug manufacturing plant |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | GAP Analysis of Pharmaceutical Manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | GAP Analysis of Pharmaceutical Manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | GMP training |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | GMP training |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits for pharmaceutical manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits for pharmaceutical manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Proxy audits of API Manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Review of basic design for pre-filled syringe manufacturing line installation |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Review of layout design (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Review of SOP (GMP) |
| 2021 | Pharmaceutical | GMP | Medicine manufacturer | Support for improving manufacturing records (GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | Confirmation of the current status of the PQS at the injectable manufacturing plant(GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP analysis for pharmaceutical manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP analysis for pharmaceutical manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audit of Pharmaceutical Manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audits for pharmaceutical manufacturer (GMP) |
| 2021 | Pharmaceutical | GMP | Pharmaceutical MAH | Support for preparation of formats for paper-based GMP audits |
| 2021 | Pharmaceutical | GMP | Reagent Manufacturing and Sales Company | Review of analytical procedure validation protocols (GMP) |
| 2021 | Pharmaceutical | GMP | Trading company | Selling SOPs |
| 2021 | Pharmaceutical | GMP | Trading company | Support for preparation of formats for paper-based GMP audits |
| 2021 | Pharmaceutical | GMP | Trading company | Training of GMP audit |
| 2021 | Pharmaceutical | GQP | Trading company | GQP consulting |
| 2021 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Confirmation for CAPA plan (Investigational Drug GMP) |
| 2021 | Pharmaceutical | Investigational Drug GMP | Drug discovery company | Investigational Drug GMP consulting |
| 2021 | Pharmaceutical | Investigational Drug GMP | Drug discovery company | Investigational Drug GMP consulting |
| 2021 | Pharmaceutical | Investigational Drug GMP | Drug discovery company | Review of SOP (GMP) |
| 2021 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audits for overseas investigational drug manufacturer (Investigational Drug GMP) |
| 2021 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | Confirmation for CAPA plan (Investigational Drug GMP) |
| 2021 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2021 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for change of Critical Control Parameter |
| 2021 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation for Stability Testing |
| 2021 | Pharmaceutical | QMS | Event company | CSA seminar |
| 2021 | Regenerative medicine | GCTP | Educational corporation | Support for revision of SOPs (GCTP) |
| 2021 | Regenerative medicine | GCTP | Regenerative medicine MAH | GCTP consulting |
| 2021 | Regenerative medicine | GCTP | Regenerative medicine MAH | Proxy audits of regenerative medicine products Manufacturer (GCTP) |
| 2021 | Regenerative medicine | Investigational Drug GMP | Educational corporation | SOP's and record review for regenerative medicine products |
| 2021 | Regenerative medicine | Others | Medical device MAH | Investigation of development data for regenerative medicine combination products |
| 2021 | Regenerative medicine | QSR | Medical device MAH | GAP analysis in the development of regenerative medicine combination products |
| 2021 | Regenerative medicine | QSR | Medical device MAH | Investigation of regenerative medicine combination product development data for export to the U.S. |
| 2021 | Medical device | CSV | Medical device MAH | CSV consultation for warehouse management system installation |
| 2021 | Medical device | CSV | Medical device MAH | CSV consultation for warehouse management system installation |
| 2021 | Medical device | CSV | Medical device MAH | CSV verification for ERP installation |
| 2021 | Medical device | CSV | Medical device MAH | Project promotion support for warehouse management system installation |
| 2021 | Medical device | CSV | Medical device MAH | Review of vendor specifications for ERP system installation |
| 2021 | Medical device | CSV | Medical device MAH | Verification of ERP system installation |
| 2021 | Medical device | QMS | Medical device MAH | Construction support of QMS system |
| 2021 | Medical device | QMS | Medical device MAH | Construction support of QMS system |
| 2021 | Medical device | QMS | Medical device MAH | Explanation of QMS overview |
| 2021 | Medical device | QMS | Medical device MAH | Review of layout design (QMS) |
| 2021 | Medical device | QMS | Medical device MAH | Review of PQ protocol (QMS) |
| 2021 | Medical device | QMS | Medical device MAH | Review of PQ protocol (QMS) |
| 2021 | Medical device | QMS | Medical device MAH | Review of PQ report (QMS) |
| 2021 | Medical device | QMS | Medical device MAH | Support for QMS Organization Establishment |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Advice for CAPA plan (cGMP) |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Confirmation of improvement status (cGMP) |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Consulting on item addition (cGMP) |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | CSV consulting (cGMP) |
| 2021 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Review of CAPA plan (cGMP) |
| 2021 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | GAP Analysis (Cosmetic GMP) |
| 2021 | Material | GMP | Material manufacturer | Consultation for Construction of Rubber Plug Manufacturing Plant |
| 2021 | Material | GMP | Material manufacturer | GMP training |
| 2021 | Material | GMP | Material manufacturer | Investigations of the current plant for the construction of a new plant |
| 2021 | Material | GMP | Material manufacturer | Support for preliminary study of equipment and facilities for new factory |
| 2021 | Material | GMP | Material manufacturer | Support for preliminary study of manufacturing process |
| 2021 | Material | GMP | Material manufacturer | Support for preliminary study of packaging specifications |
| 2021 | Construction | CSV | Construction company | CSV document review and meetings for warehouse construction |
| 2021 | Construction | GMP | Construction company | Basic design support for the construction of an injectable drug manufacturing plant |
| 2021 | Construction | GMP | Construction company | Competition support as an inner consultant (GMP) |
| 2021 | Construction | GMP | Construction company | Design review and meeting regarding warehouse construction (GMP) |
| 2021 | Construction | GMP | Construction company | Detailed design support for the construction of an injectable drug manufacturing plant |
| 2021 | Construction | GMP | Construction company | IOQ document review and meetings regarding warehouse construction |
| 2021 | Construction | GMP | Construction company | Specification review and meetings regarding warehouse construction |
| 2021 | Equipment | cGMP | Equipment sales company | Validation training for equipment manufacturers (cGMP) |
| 2021 | Equipment | GMP | Equipment sales company | Validation training for equipment suppliers |
| 2021 | Equipment | QMS | Equipment sales company | Validation training for equipment manufacturers (QMS) |
| 2021 | Others | CSV | Clinical laboratory testing company | Creation of a validation plan for the installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | CSV consulting for installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | CSV documentation support for installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | CSV documentation support for the installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | Risk assessment support for installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | Risk assessment support for installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | Validation report review for installation of a scratch system |
| 2021 | Others | CSV | Clinical laboratory testing company | Validation report review for installation of a scratch system |
| 2020 | Pharmaceutical | cGMP | API manufacturer | FDA Mock inspection (cGMP) |
| 2020 | Pharmaceutical | cGMP | API manufacturer | Review of investigational drug records |
| 2020 | Pharmaceutical | cGMP | API manufacturer | Training/Preparation for FDA Mock inspection (cGMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Construction support of GMP document system (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Construction support of GMP organization (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | DI/ CSV training (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | GMP consulting for investigational drug manufacturer |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | GMP training (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Lecture SOP temprate (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Making SOP temprate (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Review and Q&A SOP (Investigational Drug GMP) |
| 2020 | Pharmaceutical | cGMP | Pharmaceutical MAH | Review of basic design for the construction of a pharmaceutical manufacturing facility (cGMP) |
| 2020 | Pharmaceutical | CSV | API manufacturer | CSV support for LIMS installation |
| 2020 | Pharmaceutical | GMP | API manufacturer | GMP consulting for a API manufacturer |
| 2020 | Pharmaceutical | GMP | Event company | CSV seminar for packaging equipment |
| 2020 | Pharmaceutical | GMP | Foundation | Seminar of FDF development for Japanese market |
| 2020 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audit of Pharmaceutical Manufacturer (GMP) |
| 2020 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of GMP procedures for a pharmaceutical manufacturer |
| 2020 | Pharmaceutical | GMP | Trading company | Proxy audit of animal drug manufacturer (GMP) |
| 2020 | Pharmaceutical | GQP | Pharmaceutical MAH | Research for outsourcing contractor |
| 2020 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Confirmation for CAPA plan (Investigational Drug GMP) |
| 2020 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Confirmation for CAPA plan (Investigational Drug GMP) |
| 2020 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Proxy audit of overseas investigational drug API manufacturer (Investigational Drug GMP) |
| 2020 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Review of CAPA plan (Investigational Drug GMP) |
| 2020 | Pharmaceutical | Investigational Drug GMP | Pharmaceutical MAH | GAP Analysis of investigational drug manufacturer (Investigational Drug GMP) |
| 2020 | Pharmaceutical | Investigational Drug GMP | Wearhouse company | GMP audit of Pharmaceutical Manufacturer |
| 2020 | Pharmaceutical | PMD Act | API manufacturer | DMF consultation |
| 2020 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2020 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2020 | Pharmaceutical | PMD Act | Foundation | Application support for Accredetation of Foreign Manufacturer |
| 2020 | Pharmaceutical | PMD Act | Foundation | Regulation consulting |
| 2020 | Pharmaceutical | PMD Act | Trading company | Regulation consulting |
| 2020 | Pharmaceutical | PMD Act | Trading company | Support of MF inquiry response from PMDA |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Confirmation for consistency between documents and operation (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Current situation analysis/consultation for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | GCTP consulting |
| 2020 | Regenerative medicine | GCTP | Educational corporation | GMP/ GCTP training |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Making document system diagram for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Making documents for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Making SOPs for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Making SOPs for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Making SOPs for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Review documents for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Educational corporation | Training of GCTP/GxP for regenarative medicine's factory (GCTP) |
| 2020 | Regenerative medicine | GCTP | Regenerative medicine MAH | GAP analysis for a regenerative medicine manufacturer (GCTP) |
| 2020 | Regenerative medicine | GCTP | Regenerative medicine MAH | GCTP training |
| 2020 | Regenerative medicine | GCTP | Regenerative medicine MAH | Review for stabiity study report of regenerative medicine (GCTP) |
| 2020 | Medical device | CSV | Medical device MAH | CSV consulting for ERP system installation |
| 2020 | Medical device | CSV | Medical device MAH | CSV development documentation for ERP system installation |
| 2020 | Medical device | CSV | Medical device MAH | CSV support for ERP system installation (verification) |
| 2020 | Medical device | CSV | Medical device MAH | Review of CSV vendor's specifications (QMS) |
| 2020 | Medical device | QMS | Medical device MAH | Special adviser of medical devices company (QMS) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Construction management (cGMP) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | FDA Mock inspection of API Manufacturer (cGMP) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Making basic engineering design and masterplan of factory construction (cGMP) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Making detailed design of factory construction (cGMP) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Qualification/Validation of factory construction (cGMP) |
| 2020 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Select for factory construction contractor/supplier of factory construction (cGMP) |
| 2020 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | GAP Analysis of Cosmetics Manufacturer (Cosmetic GMP) |
| 2020 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP Analysis of Cosmetic Ingredient Manufacturer (EFfCI GMP) |
| 2020 | Construction | GMP | Construction company | Special adviser of construction company for getting construction project in pharmaceutical industry (GMP) |
| 2020 | Others | CSV | Clinical laboratory testing company | CSV consulting for installation of a scratch system |
| 2020 | Others | CSV | Clinical laboratory testing company | CSV documentation support for installation of a scratch system |
| 2020 | Others | PMD Act | Cosmetic MAH | Research of claim/advertisement risk in Japan against medicated toothpasete from overseas country |
| 2020 | Others | PMD Act | Cosmetic MAH | Research of how-to import medicated toothpasete in Japan from overseas country |
| 2020 | Others | PMD Act | Cosmetic MAH | Research of how-to register as quasi-drug in Japan against medicated toothpaste from overseas country |
| 2020 | Others | PMD Act | Cosmetic MAH | Research of regulation in Japan against medicated toothpaste from overseas country |
| 2020 | Others | PMD Act | Quasi-drug MAH | Consultation for application of quasi-drug |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Attend as an observer on inspection by authority |
| 2019 | Pharmaceutical | cGMP | API manufacturer | cGMP consulting for API Manufacturer |
| 2019 | Pharmaceutical | cGMP | API manufacturer | FDA Mock inspection (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | GAP Analysis (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | GMP training (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Install PQS (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Making documents(cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Review of documents for application |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Review of PV report (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Support for improvement (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Support qualification (cGMP) |
| 2019 | Pharmaceutical | cGMP | API manufacturer | Support validation (cGMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | Cosultation of deviation SOP and record (GMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | FDA inspection training (cGMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | FDA Mock inspection (cGMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | Lecture of observations (cGMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | Support of CAPA (cGMP) |
| 2019 | Pharmaceutical | cGMP | Pharmaceutical MAH | Training of deviation (GMP) |
| 2019 | Pharmaceutical | GCP | Pharmaceutical MAH | Consulting for FDF development (GCP) |
| 2019 | Pharmaceutical | GDP | Consultant | GDP seminar |
| 2019 | Pharmaceutical | GDP | Logistics company | GAP Analysis (GDP) |
| 2019 | Pharmaceutical | GDP | Logistics company | GDP training |
| 2019 | Pharmaceutical | GDP | Logistics company | Investigation for constructing GDP organization |
| 2019 | Pharmaceutical | GDP | Logistics company | Proxy audit of investigational drug storage contractors (GDP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Audit support (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Audit support (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | CAPA training (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Checking SOPs and records (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Consulting of wholeseller's license (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Discussion how to get wholeseller's license (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | GAP Analysis of API Manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP consulting |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP consulting for API Manufacturer |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP consulting for API Manufacturer |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP consulting for API Manufacturer |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP improvement support for API Manufacturer |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP Ministerial Ordinance training |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP training |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP training |
| 2019 | Pharmaceutical | GMP | API manufacturer | GMP training of API Manufacturer |
| 2019 | Pharmaceutical | GMP | API manufacturer | Investigation of GMP documents (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Making PQ protocol draft for HPAPI (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Proxy audit of API Manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Proxy audit of API Manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Review of SOP (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Review PQ protocol for HPAPI (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Supprort for making SOP (GMP) |
| 2019 | Pharmaceutical | GMP | API manufacturer | Training of wholeseller (GMP) |
| 2019 | Pharmaceutical | GMP | Foundation | Training of practical QC (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Attend as an observer on tech-transfer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Construction support of GMP organization (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Construction support of GMP system (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | GAP Analysis of overseas pharmaceutical manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP consulting |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP training |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Investigation of structure & equipments (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Making and Review of protocol for stability study |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Making and Review of PV protocol (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Making and Review of PV report (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Preparation for GMP compliance review by PMDA (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Regulatory support |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review and making support of protocol for tech-transfer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of applcation (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of GQP Agreement (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of Japanese PIF (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of Japanese PIF (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of MBR (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of Plan & Report of PV (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of Record & Report of PV (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of specification and test method (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of stability test result |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Review of tech-transfer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Self-inspection of Pharmaceutical Manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Self-inspection of Pharmaceutical Manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Support fo GMP Compliance Reviews by PMDA |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Training for operator (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Training of testing validation (GMP) |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Trend lecture of PMDA audit for overseas pharmaceutical manufacturer |
| 2019 | Pharmaceutical | GMP | Pharmaceutical MAH | Validation training (GMP) |
| 2019 | Pharmaceutical | GMP | Quasi-drug MAH | GAP Analysis of overseas pharmaceutical manufacturer (GMP) |
| 2019 | Pharmaceutical | GMP | Temporary staffing agency | GMP traiing |
| 2019 | Pharmaceutical | GMP | Temporary staffing agency | GMP traiing |
| 2019 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Proxy audit of overseas investigational drug API manufacturer (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Investigational Drug GMP | Logistics company | Review of CAPA plan (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audit of investigational drug analysis contractor (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audit of investigational drug manufacturer (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audit of investigational drug manufacturer (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Review of CAPA plan (Investigational Drug GMP) |
| 2019 | Pharmaceutical | Others | API manufacturer | Checking requirement based on categorization HPAPI |
| 2019 | Pharmaceutical | Others | API manufacturer | GAP Analysis of highly Pharmacologically Active API Manufacturer (GMP) |
| 2019 | Pharmaceutical | Others | API manufacturer | Review of DMF Closed Part |
| 2019 | Pharmaceutical | Others | Medical device manufacturer | Proxy audit of a vial stopper manufacturer |
| 2019 | Pharmaceutical | PMD Act | API manufacturer | Investigation of development documents |
| 2019 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Application support for licence of pharmaceutical product manufacturer (GMP) |
| 2019 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation of FDF development |
| 2019 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation of transfer-approval |
| 2019 | Pharmaceutical | PMD Act | Trading company | Coherent check between documents and operations (GMP) |
| 2019 | Pharmaceutical | PMD Act | Trading company | Making MF draft |
| 2019 | Pharmaceutical | PMD Act | Trading company | Making QOS draft |
| 2019 | Pharmaceutical | PMD Act | Trading company | Review of documents for MF |
| 2019 | Pharmaceutical | PMD Act | Trading company | Training of Pharmaceutical regulation |
| 2019 | Medical device | CSV | Medical device MAH | CSV support for adding QMS management system modules (Project Management) |
| 2019 | Medical device | CSV | Medical device MAH | CSV support for module addition |
| 2019 | Medical device | PMD Act | Medical device MAH | Review of application and attachements (QMS) |
| 2019 | Medical device | PMD Act | Medical device MAH | Support of PMDA's review (QMS) |
| 2019 | Medical device | QMS | Medical device MAH | Consultation of Q&A from notify body (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | Examination support (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | Examination support (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | Outsourcing study support (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | QMS support (QMS) |
| 2019 | Medical device | QMS | Medical device MAH | Risk management support (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | Self-inspection support (ISO13485) |
| 2019 | Medical device | QMS | Medical device MAH | Stability study support (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | Consultion of medical devices development |
| 2019 | Medical device | QMS | Medical device manufacturer | DI training (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | Feasibility study for getting license (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | Feasibilty study in each regions (ISO13485) |
| 2019 | Medical device | QMS | Medical device manufacturer | GAP Analysis of medical device manufacturer (ISO13485 and regulations) |
| 2019 | Medical device | QMS | Medical device manufacturer | GAP Analysis of medical device manufacturer (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | GAP Analysis of medical device manufacturer (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | GAP Analysis of medical device manufacturer (QMS) |
| 2019 | Medical device | QMS | Medical device manufacturer | Lecture of each relulations in the regions (ISO13485) |
| 2019 | Medical device | QMS | Medical device manufacturer | Medical devices consultation |
| 2019 | Medical device | QMS | Medical device manufacturer | Support feasibility study in medical decices industry |
| 2019 | Medical device | QMS | Medical device manufacturer | Support of instal QMS (ISO9001/13485) |
| 2019 | Medical device | QSR | Medical device MAH | Construction support of GMP organization (QMS) |
| 2019 | Medical device | QSR | Medical device MAH | Consultation for making answer against observation (QMS) |
| 2019 | Medical device | QSR | Medical device MAH | Consultation for re-examination (QMS) |
| 2019 | Medical device | QSR | Medical device MAH | GAP Analysis of medical device manufacturer (QSR) |
| 2019 | Medical device | QSR | Medical device MAH | Medical devices training |
| 2019 | Medical device | QSR | Medical device MAH | Review and making support of documents (QMS) |
| 2019 | Medical device | QSR | Medical device MAH | Supprort for making documents (QMS) |
| 2019 | Medical device | QSR | Medical device manufacturer | GAP Analysis of medical device manufacturer (QSR) |
| 2019 | Medical device | QSR | Medical device manufacturer | Investigation of structure & equipments |
| 2019 | Medical device | QSR | Medical device manufacturer | Making renewal consept design of structure & equipments |
| 2019 | Medical device | QSR | Medical device manufacturer | QSR & sterilization training (QSR) |
| 2019 | Medical device | QSR | Medical device manufacturer | Support for factory renovation (QSR) |
| 2019 | Medical device | QSR | Medical device manufacturer | Support for making document system based on QSR & ISO13485 |
| 2019 | Medical device | QSR | Medical device manufacturer | Supprot for factory validation |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Basic plan/design work support for new factory (cGMP) |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Review of Form 483 (cGMP) |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Support of making URS for new factory (cGMP) |
| 2019 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Validation support for new factory (cGMP) |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic ingredient manufacuturer | Consulting for development of cosmetic ingredient (Cosmetic GMP) |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Cosmetic GMP training |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic MAH | GAP Analysis (CosmeticGMP) |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Mock Inspection of Cosmetics Manufacturer (Cosmetic GMP) |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic MAH | Support for SOP modification (Cosmetic GMP) |
| 2019 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | GAP Analysis of Cosmetics Manufacturer (Cosmetic GMP) |
| 2019 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | CSV support for new factory (cGMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Construction support of GMP organization(EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP Analysis of Cosmetic Ingredient Manufacturer (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Investigation of drawing and equimment (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Lecture SOP temprate (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Making template of SOPs (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Review of SOP (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Support for making document system (EFfCI GMP) |
| 2019 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | Training and Q&A of GMP (EFfCI GMP) |
| 2019 | Material | QMS | Medical device manufacturer | Basic training of Medical Devices (QMS) |
| 2019 | Material | QMS | Medical device manufacturer | Consulting way of sterilization, and suitable equipment (QMS) |
| 2019 | Material | QMS | Medical device manufacturer | Feasibility study support (QMS) |
| 2019 | Material | QMS | Medical device manufacturer | Feasibility study support of layout (QMS) |
| 2019 | Material | QMS | Medical device manufacturer | Support for estimation of cost (QMS) |
| 2019 | Material | QMS | Medical device manufacturer | Support of line layout (QMS) |
| 2019 | Construction | cGMP | Construction company | cGMP training |
| 2019 | Construction | Cosmetic GMP | Construction company | Basic plan support (ISO22716) |
| 2019 | Construction | GMP | Construction company | Competition support as an inner consultant (GMP) |
| 2019 | Equipment | GMP | Equipment sales company | Consultation for development of medical devices |
| 2019 | Others | CSV | Clinical laboratory testing company | CSV consulting for installation of a scratch system |
| 2019 | Others | CSV | Clinical laboratory testing company | Review of CSV documentation in the installation of a scratch system |
| 2019 | Others | GMP | Analysis company | GAP Analysis of analysis contractor (GMP) |
| 2019 | Others | GMP | Analysis company | GMP consulting |
| 2019 | Others | GMP | Consultant | GMP seminar |
| 2019 | Others | GMP | Consultant | GMP seminar |
| 2019 | Others | GMP | Event company | DI seminar |
| 2019 | Others | Others | Event company | API Supply Chain Management seminar (GQP) |
| 2019 | Others | PMD Act | Consultant | Investigation of Quasi-drugs regulation |
| 2019 | Others | QMS | Foundation | Automatic recognition system seminar (QMS) |
| 2018 | Pharmaceutical | cGMP | API manufacturer | cGMP consulting |
| 2018 | Pharmaceutical | cGMP | API manufacturer | GAP Analysis of API Manufacturer (cGMP) |
| 2018 | Pharmaceutical | cGMP | API manufacturer | Mock Inspection of API manufacturer (DI) |
| 2018 | Pharmaceutical | cGMP | API manufacturer | Review of PV plan (cGMP) |
| 2018 | Pharmaceutical | EXCiPACT | API manufacturer | GAP Analysis of pharmaceutical excipients manufacturer (EXCiPACT) |
| 2018 | Pharmaceutical | GCP | Pharmaceutical MAH | Correction support of SOP (GCP) |
| 2018 | Pharmaceutical | GCP | Pharmaceutical MAH | GCP training |
| 2018 | Pharmaceutical | GCP | Pharmaceutical MAH | Making SOP temprate (GCP) |
| 2018 | Pharmaceutical | GDP | Certification body | Seminar of GDP |
| 2018 | Pharmaceutical | GMP | API manufacturer | GAP Analysis of API manufacturers (DI) |
| 2018 | Pharmaceutical | GMP | API manufacturer | GAP analysis of overseas API manufacture (GMP) |
| 2018 | Pharmaceutical | GMP | API manufacturer | GMP auditor training |
| 2018 | Pharmaceutical | GMP | API manufacturer | GMP document maintenance and document system reconstruction support |
| 2018 | Pharmaceutical | GMP | API manufacturer | GMP training |
| 2018 | Pharmaceutical | GMP | API manufacturer | Lecture SOP temprate (GMP), and discussion plan |
| 2018 | Pharmaceutical | GMP | API manufacturer | Lecture SOP temprate (GMP), and discussion plan |
| 2018 | Pharmaceutical | GMP | API manufacturer | Making SOP temprate (GMP) |
| 2018 | Pharmaceutical | GMP | API manufacturer | Making SOP temprate (GMP) |
| 2018 | Pharmaceutical | GMP | API manufacturer | Review and Q&A SOP (GMP) |
| 2018 | Pharmaceutical | GMP | API manufacturer | Review and Q&A SOP (GMP) |
| 2018 | Pharmaceutical | GMP | API manufacturer | Review of basic design (GMP) |
| 2018 | Pharmaceutical | GMP | Consultant | Seminar of PMD Act & GMP |
| 2018 | Pharmaceutical | GMP | Foundation | GMP training (basic QC) |
| 2018 | Pharmaceutical | GMP | Foundation | GMP training (practical QC) |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | DI consultation |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | DI training |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP training |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP training (Self-inspection) |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | GMP training (supplier audit) |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Operation verification support based on PMS |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Operation verification support based on PMS |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Operation verification support based on PQS |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Operation verification support based on PQS |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Operation verification support based on PQS |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audit of API manufacturer (GMP) |
| 2018 | Pharmaceutical | GMP | Pharmaceutical MAH | Proxy audit of API Manufacturer (GMP) |
| 2018 | Pharmaceutical | GMP | Printing company | Seminar of QA for new drug development |
| 2018 | Pharmaceutical | GMP | Trading company | GAP Analysis of pharmaceutical manufacture (packaging, labeling, storage) (GMP) |
| 2018 | Pharmaceutical | GMP | Trading company | Making GMP documents and operation support |
| 2018 | Pharmaceutical | GMP | Trading company | Training of SOP (GMP) |
| 2018 | Pharmaceutical | GQP | Pharmaceutical MAH | Coherent check between documents and operations(API) |
| 2018 | Pharmaceutical | GQP | Pharmaceutical MAH | Coherent check between documents and operations(FDF) |
| 2018 | Pharmaceutical | GQP | Pharmaceutical MAH | Coherent check between SOPs (GMP) |
| 2018 | Pharmaceutical | GQP | Pharmaceutical MAH | Support for revision of internal QA regulations |
| 2018 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Proxy audit of investigational API manufacturer (Investigational Drug GMP) |
| 2018 | Pharmaceutical | Investigational Drug GMP | API manufacturer | Proxy audit of investigational API manufacturer (Investigational Drug GMP) |
| 2018 | Pharmaceutical | Investigational Drug GMP | Medicine manufacturer | Proxy audit of investigational drug packaging contractor (Investigational Drug GMP) |
| 2018 | Pharmaceutical | Investigational Drug GMP | Wearhouse company | Proxy audit of investigational API manufacturer (Investigational Drug GMP) |
| 2018 | Pharmaceutical | KGMP | Pharmaceutical MAH | GAP Analysis of Pharmaceutical Manufacturer (KGMP) |
| 2018 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Consultation of development and regulation |
| 2018 | Pharmaceutical | PMD Act | Pharmaceutical MAH | DMF consultation |
| 2018 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Regulation consulting |
| 2018 | Pharmaceutical | PMD Act | Pharmaceutical MAH | Research for development and regulation |
| 2018 | Medical device | CSV | Medical device MAH | CSV support for adding QMS management system modules (Project Management) |
| 2018 | Medical device | CSV | Medical device manufacturer | ER/ES support for core systems |
| 2018 | Medical device | GMP | Medical device manufacturer | Training GMP and engineering |
| 2018 | Medical device | QMS | Medical device MAH | Attend as an observer on PQ |
| 2018 | Medical device | QMS | Medical device MAH | Attend as an observer on PV |
| 2018 | Medical device | QMS | Medical device MAH | Consultation Medical devices business |
| 2018 | Medical device | QMS | Medical device MAH | Consultation of Pharmacetuticals/Meical devices business |
| 2018 | Medical device | QMS | Medical device MAH | Making SOP support based on ER/ES |
| 2018 | Medical device | QMS | Medical device MAH | Making support of Valdation plan |
| 2018 | Medical device | QMS | Medical device MAH | Review for validation plan (DQ・IQ・OQ・PQ) |
| 2018 | Medical device | QMS | Medical device MAH | Review for validation report (DQ・IQ・OQ・PQ) |
| 2018 | Medical device | QMS | Medical device MAH | Review of Validation record |
| 2018 | Medical device | QMS | Medical device MAH | Support for selection of vendor/specification |
| 2018 | Medical device | QSR | Medical device MAH | Review and making support of documents (CSV) |
| 2018 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | cGMP training |
| 2018 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Design review and meeting for new factory construction |
| 2018 | Cosmetic | cGMP | Cosmetic ingredient manufacuturer | Review of validation documents for new factory construction |
| 2018 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | GAP Analysis of Cosmetics Manufacturer (Cosmetic GMP) |
| 2018 | Cosmetic | Cosmetic GMP | Cosmetic manufacturer | GAP Analysis of cosmetics manufacturers (ISO22716) |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | CSV support for DCS installation (Draft of development plan) |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | DQ evaluation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | FS preparation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | IQ documentation and evaluation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | OQ documentation and evaluation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | PQ document preparation and evaluation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | Support for DS document preparation for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | Support for preparation of validation plan for DCS installations |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | URS preparation support for DCS installation |
| 2018 | Cosmetic | CSV | Cosmetic ingredient manufacuturer | Validation report writing for DCS installation |
| 2018 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | EFfCI GMP training |
| 2018 | Cosmetic | EFfCI | Cosmetic ingredient manufacuturer | GAP Analysis of Cosmetic Ingredient Manufacturer (EFfCI GMP) |
| 2018 | Cosmetic | EFfCI | Supplement ingredient manufacturer | Investigation of SOPs (EFfCI) |
| 2018 | Cosmetic | EXCiPACT | Cosmetic ingredient manufacuturer | GAP Analysis of pharmaceutical excipients manufacturer (EXCiPACT) |
| 2018 | Cosmetic | GCP | Cosmetic ingredient manufacuturer | Proxy audit of overseas testing outsourcing partners (GCP) |
| 2018 | Others | CSV | Clinical laboratory testing company | PQ support for QMS management system installation |
| 2018 | Others | CSV | Clinical laboratory testing company | Review of vendor documentation for QMS management system installation |
| 2018 | Others | CSV | Clinical laboratory testing company | Support for preparation of project reports for QMS management system installation |
| 2018 | Others | CSV | Clinical laboratory testing company | Support for preparation of validation plans for QMS management system installations |
| 2018 | Others | CSV | Clinical laboratory testing company | System training for QMS management system installation |
| 2018 | Others | CSV | Clinical laboratory testing company | URS creation support for QMS management system installation |
| 2018 | Others | GMP | Consultant | GMP seminar |
| 2018 | Others | GMP | Temporary staffing agency | Attend as an observer on GMP seminar |
The same performance records are included in the initial HTML so the content remains readable even when JavaScript is unavailable.
